M
Mahnaz Amini
Researcher at Mashhad University of Medical Sciences
Publications - 48
Citations - 396
Mahnaz Amini is an academic researcher from Mashhad University of Medical Sciences. The author has contributed to research in topics: Medicine & Obstructive sleep apnea. The author has an hindex of 8, co-authored 42 publications receiving 218 citations.
Papers
More filters
Journal ArticleDOI
Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial.
Niloofar Saber-Moghaddam,Soofia Salari,Sepideh Hejazi,Mahnaz Amini,Zhila Taherzadeh,Saeed Eslami,Seyed Mahdi Rezayat,Mahmoud Reza Jaafari,Sepideh Elyasi +8 more
TL;DR: Wang et al. as mentioned in this paper proposed nano-curcumin as a potential treatment option for coronavirus disease-19 (COVID-19) by inhibiting the virus entrance, encapsulation and replication, and modulating various cellular signaling pathways.
Journal ArticleDOI
Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.
Mojtaba Abrishami,Fariba Tohidinezhad,Ramin Daneshvar,Arash Omidtabrizi,Mahnaz Amini,Alireza Sedaghat,Shahram Amini,Hamidreza Reihani,Abolghasem Allahyari,Mohsen Seddigh-Shamsi,Mohammad Tayyebi,HamidReza Naderi,Amin Bojdy,Rozita Khodashahi,Saeid Eslami,Saeid Eslami +15 more
TL;DR: Ocular manifestation was observed in more than half of the COVID-19 patients, and it seems important to involve ophthalmologist in the diagnosis and management of these patients.
Journal ArticleDOI
Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: A systematic review and meta-analysis.
Ahmadreza Zarifian,Mohammad Zamiri Bidary,Soheil Arekhi,Mahdi Rafiee,Hanieh Gholamalizadeh,Amirhosein Amiriani,Mohammad Sajjad Ghaderi,Majid Khadem-Rezaiyan,Mahnaz Amini,Azita Ganji +9 more
TL;DR: Gastrointestinal and liver manifestations are not rare in patients with COVID‐19, but their prevalence might be affected by preexisting diseases.
Journal ArticleDOI
Pulmonary hydatid cyst : analysis of 1024 cases
TL;DR: In this article, the authors evaluated outcomes of patients with pulmonary hydatid disease who were treated in a hospital in South Africa, and found that the outcomes of these patients were worse than those of those who were not treated in the hospital.
Journal ArticleDOI
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
Abolghasem Allahyari,Mohsen Seddigh-Shamsi,Mahmoud Mahmoudi,Saeid Amel Jamehdar,Mahnaz Amini,Mahnaz Mozdourian,Zahra Javidarabshahi,Saeed Eslami Hasan Abadi,Shahram Amini,Alireza Sedaghat,Maryam Emadzadeh,Mohammad Moeini Nodeh,Hossein Rahimi,Alireza Bari,Zahra Mozaheb,Mostafa Kamandi,Sajad Ataei Azimi,Mojtaba Abrishami,Arezoo Akbarian,Parisa Ataei,Negin Allahyari,Sepideh Hasanzadeh,Neda Saeedian +22 more
TL;DR: Early administration of the convalescent plasma could successfully contribute to the treatment of severe COVID-19 patients with mild or moderate ARDS at risk of progressing to critical state.